Epilepsy surgery in children and adolescents: Report on 43 cases

Marina Aberastury1, Betina Comas2, María García2

  • 1Hospital Italiano, Ciudad Autónoma de Buenos Aires, Argentina. marina.aberastury@hiba.org.ar.

Insights

Pediatric epilepsy surgery offers effective seizure control for refractory cases. Early intervention and complete removal of the epileptogenic zone improve outcomes for children with epilepsy.

Area of Science:

  • Pediatric Neurology
  • Neurosurgery
  • Epileptology

Background:

  • Refractory epilepsy in children poses significant challenges.
  • Epilepsy surgery is a key treatment for drug-resistant epilepsy.
  • Careful patient selection is crucial for successful surgical outcomes.

Purpose of the Study:

  • To evaluate the effectiveness and safety of epilepsy surgery in pediatric patients.
  • To identify prognostic factors influencing surgical outcomes.
  • To report on a consecutive series of 43 pediatric epilepsy surgeries.

Main Methods:

  • Retrospective analysis of 43 pediatric patients undergoing epilepsy surgery (September 2005 - May 2014).
  • Procedures included resective surgery (32 patients) and hemispherectomy (11 patients).
  • Analysis of seizure control, safety, and prognostic indicators.

Main Results:

  • 62.8% of patients achieved sustained seizure freedom post-surgery.
  • Median follow-up duration was 5.4 years.
  • Shorter epilepsy duration (<2 years) and complete epileptogenic zone resection correlated with better prognosis.

Conclusions:

  • Epilepsy surgery is an effective and safe treatment for refractory pediatric epilepsy.
  • Timely surgical intervention and achieving complete resection are vital for optimal outcomes.
  • Further research into prognostic factors can refine patient selection for epilepsy surgery.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.8K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
2.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K